Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SYRS · against 1,372 other Healthcare companies
Ranked #1,340 of 1,373 · scores higher than 2% of peers · safety percentile 2
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)138 peers with a safety percentile of 0–9, including SYRS · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | SYRS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | Not reported | 0.24× | — | — | 33% |
| BetaLower is better · 1,320 reported | 1.73 | 0.53 | 8% | 33% | |
| Current ratioHigher is better · 1,338 reported | 2.25× | 2.62× | 45% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 1,336 | 4.6B USD | 3 | 61 | |
| 1,337 | 198M USD | 3 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 10 |
| 1,338 | 301M USD | 3 | 67 |
| 1,339 | 115M USD | 2 | 8 |
| 1,340 | 0M USD | 2 | 1 |
| 1,341 | 649M SEK (≈$65M) | 2 | 29 |
| 1,342 | 126M USD | 2 | 32 |
| 1,343 | 14.0B USD | 2 | 31 |
| 1,344 | 1.2B CHF (≈$1.4B) | 2 | 34 |